About Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz
During the past decade, Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
2015-03-31
2020-12-07
Completed
1,202
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
2015-10-31
2027-12-17
Active, not recruiting
1,280
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz
According to Clinical.Site data, the most researched conditions in "Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz" are
"Carcinoma, Non-Small-Cell Lung" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz" in a lesser frequency.
Clinical Trials Intervention Types at Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz
Most popular intervention types in "Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz
The vast majority of trials in "Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz" are
2 trials for "All" genders.
Clinical Trials Status at Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz
Currently, there are NaN active trials in "Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kliniken der Stadt Koln gGmbH; Lungenklinik Onkologische Ambulanz, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".